RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay Inc. (AMEX:ISR) a medical isotope company focusing on the treatment of prostate and other malignant disease through use of its proprietary radioisotope technology, announces its financial results for the quarter and year ended June 30, 2007.
